149 related articles for article (PubMed ID: 23359207)
1. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Garnett J; Chumbalkar V; Vaillant B; Gururaj AE; Hill KS; Latha K; Yao J; Priebe W; Colman H; Elferink LA; Bogler O
Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
[TBL] [Abstract][Full Text] [Related]
2. EGFR Activates a TAZ-Driven Oncogenic Program in Glioblastoma.
Gao M; Fu Y; Zhou W; Gui G; Lal B; Li Y; Xia S; Ji H; Eberhart CG; Laterra J; Ying M
Cancer Res; 2021 Jul; 81(13):3580-3592. PubMed ID: 33910930
[TBL] [Abstract][Full Text] [Related]
3. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma.
Jun HJ; Bronson RT; Charest A
Stem Cells; 2014 Feb; 32(2):338-48. PubMed ID: 24115218
[TBL] [Abstract][Full Text] [Related]
5. Aberrant
Al-Ghabkari A; Huang B; Park M
Cells; 2024 Jan; 13(3):. PubMed ID: 38334610
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling.
Gao X; Xia X; Li F; Zhang M; Zhou H; Wu X; Zhong J; Zhao Z; Zhao K; Liu D; Xiao F; Xu Q; Jiang T; Li B; Cheng SY; Zhang N
Nat Cell Biol; 2021 Mar; 23(3):278-291. PubMed ID: 33664496
[TBL] [Abstract][Full Text] [Related]
7. The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth.
Franco M; Muratori C; Corso S; Tenaglia E; Bertotti A; Capparuccia L; Trusolino L; Comoglio PM; Tamagnone L
J Biol Chem; 2010 Dec; 285(50):38756-64. PubMed ID: 20937830
[TBL] [Abstract][Full Text] [Related]
8. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional control of brain tumor stem cells by a carbohydrate binding protein.
Sharanek A; Burban A; Hernandez-Corchado A; Madrigal A; Fatakdawala I; Najafabadi HS; Soleimani VD; Jahani-Asl A
Cell Rep; 2021 Aug; 36(9):109647. PubMed ID: 34469737
[TBL] [Abstract][Full Text] [Related]
10. MET signaling regulates glioblastoma stem cells.
Joo KM; Jin J; Kim E; Ho Kim K; Kim Y; Gu Kang B; Kang YJ; Lathia JD; Cheong KH; Song PH; Kim H; Seol HJ; Kong DS; Lee JI; Rich JN; Lee J; Nam DH
Cancer Res; 2012 Aug; 72(15):3828-38. PubMed ID: 22617325
[TBL] [Abstract][Full Text] [Related]
11. The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma.
Bill KL; Garnett J; Ma X; May CD; Bolshakov S; Lazar AJ; Lev DC; Pollock RE
Lab Invest; 2015 Aug; 95(8):951-61. PubMed ID: 26006023
[TBL] [Abstract][Full Text] [Related]
12. MET in glioma: signaling pathways and targeted therapies.
Cheng F; Guo D
J Exp Clin Cancer Res; 2019 Jun; 38(1):270. PubMed ID: 31221203
[TBL] [Abstract][Full Text] [Related]
13. LPA
Valdés-Rives SA; Arcos-Montoya D; de la Fuente-Granada M; Zamora-Sánchez CJ; Arias-Romero LE; Villamar-Cruz O; Camacho-Arroyo I; Pérez-Tapia SM; González-Arenas A
Cells; 2021 Apr; 10(4):. PubMed ID: 33916643
[TBL] [Abstract][Full Text] [Related]
14. Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells.
Huang KH; Sung IC; Fang WL; Chi CW; Yeh TS; Lee HC; Yin PH; Li AF; Wu CW; Shyr YM; Yang MH
Oncol Rep; 2018 Jul; 40(1):294-302. PubMed ID: 29781036
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF.
Hynds RE; Gowers KHC; Nigro E; Butler CR; Bonfanti P; Giangreco A; Prêle CM; Janes SM
PLoS One; 2018; 13(5):e0197129. PubMed ID: 29771943
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases.
Wang C; Xi W; Ji J; Cai Q; Zhao Q; Jiang J; Zhou C; Shi M; Zhang H; Zhu Z; Zhang J
Int J Med Sci; 2020; 17(13):1946-1955. PubMed ID: 32788873
[TBL] [Abstract][Full Text] [Related]
17. Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
Kenchappa RS; Dovas A; Argenziano MG; Meyer CT; Stopfer LE; Banu MA; Pereira B; Griffith J; Mohammad A; Talele S; Haddock A; Zarco N; Elmquist W; White F; Quaranta V; Sims P; Canoll P; Rosenfeld SS
Cell Rep; 2022 Jun; 39(12):110991. PubMed ID: 35732128
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
Yin J; Seo Y; Rhim J; Jin X; Kim TH; Kim SS; Hong JH; Gwak HS; Yoo H; Park JB; Kim JH
Cancer Res; 2023 Nov; 83(22):3693-3709. PubMed ID: 37747775
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection of glioblastoma cells leads to NF-κB dependent upregulation of the c-MET oncogenic tyrosine kinase.
Krenzlin H; Zdioruk M; Nowicki MO; Finkelberg T; Keric N; Lemmermann N; Skubal M; Chiocca EA; Cook CH; Lawler SE
Cancer Lett; 2021 Aug; 513():26-35. PubMed ID: 33989707
[TBL] [Abstract][Full Text] [Related]
20. Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme.
Jun HJ; Acquaviva J; Chi D; Lessard J; Zhu H; Woolfenden S; Bronson RT; Pfannl R; White F; Housman DE; Iyer L; Whittaker CA; Boskovitz A; Raval A; Charest A
Oncogene; 2012 Jun; 31(25):3039-50. PubMed ID: 22020333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]